Opening snapshot Pharmaceutical Industry 2025 is the year pharma moves from promise to production: advances in AI and precision science are accelerating R&D, biosimilars are gaining market share as biologic patents expire, and governments and regulators are pushing for stronger manufacturing and supply-chain resilience. At the same time, pricing pressure and evolving policy environments are …
1/8/2025 – Chandigarh (Publish by – Allcure Remedies) In today’s dynamic pharmaceutical landscape, Big Pharma companies are seeking faster, smarter, and more cost-effective ways to bring therapies to market. One key driver of this transformation is the rise of strategic collaborations with Contract Development and Manufacturing Organizations (CDMOs). What started as a cost-saving outsourcing tactic …
The Contract Development and Manufacturing Organization (CDMO) market is experiencing rapid growth across the globe. As pharmaceutical companies increasingly look to outsource drug development and manufacturing, CDMOs are stepping up with advanced capabilities, innovative solutions, and global scalability. Among the top regions leading this charge are the United States, European Union, and India—each playing a …
